Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Abstract

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and is accompanied by neuron loss and structure change. With the increase of AD patients worldwide, the pathology and treatment of the disease has become a focus in the International Pharmaceutical Industry. Thus, the establishment of the animal model to mimic AD in the laboratory is of great importance.Here, we describe a detailed protocol for establishing a mimic of AD in a rat animal model though intracerebroventricular injection of amyloid beta protein 25-35 (Aβ25-35) combined with aluminum trichloride (AlCl3) and anterodorsal thalamic nucleus injection of recombinant human transforming growth factor-β1 (RHTGF-β1) to rats. The related markers of AD were measured, including: spatial memory, neuronal structure and substructure, neuronal Aβ, and neurofibrillary tangles (NFT) production. This rat model demonstrates spatial memory impairment, neuronal structure and substructure pathological changes, neuron intracellular Aβ burden, and NFT aggregation, and provides a close mimic of the neuronal structure and function disorder to that of clinical AD patients. Thus, the presented AD rat modelprovides a valuable in vivo tool for exploring neuronal function, neuronal pathology, and drug screening of AD.

Neuroprotective effect of naringin against cerebellar changes in Alzheimer’s disease through modulation of autophagy, oxidative stress and tau expression: An experimental study

“…AD is accompanied by neuronal loss and structural changes (Xiaoguang et al, 2018). Short-term memory impairment is the first clinical sign of AD due to hippocampal neuronal degeneration (Lakshmi et al, 2015).…”

Combination of Lanosterol and Nilvadipine Nanosuspensions Rescues Lens Opacification in Selenite-Induced Cataractic Rats

“…The selenite cataract is an animal model of cataracts produced in suckling rat pups [ 18 , 19 , 20 , 21 , 22 , 23 ] that presents with calpain-induced proteolysis, suppression of mitosis, decreased rate of epithelial cell differentiation, and cytoskeletal loss [ 14 , 24 ]. These characteristics of the model animals are similar to those seen clinically in humans, and this model has widely been used in many studies as a useful in vivo model for the initial screening of potential anti-cataract agents.…”

Kaempferide prevents cognitive decline via attenuation of oxidative stress and enhancement of brain‐derived neurotrophic factor/tropomyosin receptor kinase B/cAMP response element‐binding signaling pathway

“…Then, injection of Aβ 1–42 mimics the amyloid toxicity and endogenous accumulation as observed in AD physiopathology. It has been suggested that Aβ 1–42 injection could serve as a useful animal model of AD (Xiaoguang et al, ).…”